Henoch-Schönlein purpura: An atypical cause of abdominal pain in a 70-year-old man

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 7-8, 2009, Pages 509-513

  Kunicka, Anita ^a   Pruszczyk, Piotr ^a   Kryst, Alicja ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Adults; Henoch Sch nlein purpura; Symptoms; Treatment

Indexed keywords

ANTIBIOTIC AGENT; DAPSONE; PREDNISONE;

ABDOMINAL PAIN; AGED; ANAPHYLACTOID PURPURA; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; CASE REPORT; CHOLESTASIS; CLINICAL FEATURE; DIARRHEA; DISEASE COURSE; DRUG INDUCED HEADACHE; FATIGUE; HEMOLYTIC ANEMIA; HEPATITIS; HUMAN; HYPOTHYROIDISM; INCIDENCE; KIDNEY DISEASE; LABORATORY TEST; MALE; METHEMOGLOBINEMIA; NAUSEA; PERIPHERAL NEUROPATHY; PNEUMONIA; PROGNOSIS; SKIN DEFECT; SKIN INFLAMMATION; STEVENS JOHNSON SYNDROME; VOMITING;

EID: 69249114909     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Szyguła-Kotala E, Sa̧da-Cieślar M, Buszman Z, et al. [A systemic manifestation of Henoch-Schönlein purpura - case report]. Alergia Astma Immunologia. 2006; 11: 223-226. Polish.
2. Szczeklik A, Musiał J. [Systemic connective tissue diseases]. In: Szczeklik A, ed. [Internal Medicine, Vol II). Medycyna Praktyczna, Kraków. 2006: 1696. Polish.
3. Grenda R. Heroch-Schönlein nephritis. Nephrol Dial Pol. 2008, 12: 186-192.
4. Shrestha S, Sumingan N, Tan J, et al. Henoch Schönlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. Q J Med. 2006; 99: 253-265.
5. Pillebout E, Thervet E, Hill G, et al. Henoch-Schönlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002; 13: 1271-1278. (Pubitemid 34441408)
6. Sharma A, Wanchu A, Kalra N, et al. Successful treatment of severe gastrointestinal involvement in adult-onset Henoch-Schönlein purpura. Singapore Med J. 2007; 48: 1047-1050. (Pubitemid 351235266)
7. Van Der Helm-Van Mil AH, Smith AC, Pouria S, et al. Immunoglobulin A multiple myeloma presenting with Henoch-Schonlein purpura associated with reduced sialylation of IgA1. Br J Haematol. 2003; 122: 915-917. (Pubitemid 37174611)
8. Birchmore D, Sweeney C, Choudhury D, et al. IgA multiple myeloma presenting as Henoch-Schonlein purpura/polyarteritis nodosa overlap syndrome. Arthritis Reum. 1996; 39: 698-703. (Pubitemid 26118049)
9. Iqbal H, Evans A. Dapsone therapy for Henoch-Schönlein purpura: a case series. Arch Dis Child. 2005; 90: 985-986. (Pubitemid 41232361)
10. Ledermann JA, Hoffbrand BI. Dapsone in allergic vasculitis: its use in Henoch-Schönlein disease following vaccination. J R Soc Med. 1983; 76: 613-614.
11. Shin JI, Lee JS, Chung KS. Dapsone therapy for Henoch-Schönlein purpura. Arch Dis Child. 2006; 91: 714.
12. Kosseifi SG, Guha B, Nassour DN, et al. The Dapsone hypersensivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations. J Occup Med Toxicol. 2006; 1: 9. (Pubitemid 46724440)
13. Orbach H, Tishler M, Shoenfeld Y. Intravenous immunoglobulin and the kidney - a two-edged sword. Semin Arthritis Rheum. 2004; 34: 593-601. (Pubitemid 39643121)
14. Fagbemi AA, Torrente F, Hilson AJ, et al. Massive gastrointestinal haemorrhage in isolated intestinal Henoch-Schonlein purpura with response to intravenous immunoglobulin infusion. Eur J Pediatr. 2007; 166: 915-919. (Pubitemid 47101343)